Neuromyelitis optica (NMOSD) trials in Argentina

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

  Where

  Buenos Aires

  Age

  18 years and over

  People

  200 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT05966467
• Phase 3Taking people
  A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

  Where

  Ciudad Autonoma Buenos Aires, Córdoba

  Age

  2 years to 11 years

  People

  8 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT05199688 · EU 2023-507817-85-00
• Phase 2Taking people
  Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

  Where

  Parque Patricios

  Age

  2 years to 17 years

  People

  15 worldwide

  Run by

  Amgen

  See details and how to joinNCT05549258 · EU 2023-510007-22-00